Celltrion Completes Purchase of Eli Lilly’s Biopharmaceutical Plant in New Jersey
Seoul: Celltrion Inc., a major South Korean biopharmaceutical company, has completed the acquisition of a biopharmaceutical manufacturing plant in the United States, paving the way